针对大脑转移的新型T细胞疗法,驾驶座上的CD133
Anthony R Sloan1,2, Mihika Thapliyal1,3, Justin D Lathia1,2,3,4
1Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.
概括
研究人员开发了一种新的CAR-T细胞疗法,针对癌症干细胞上的CD133抗原. 这种方法旨在通过向关键癌症细胞表面标记物来改善大脑转移的治疗.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 癌症干细胞生物学
背景情况:
- 化学抗原受体 (CAR) -T细胞疗法对晚期癌症显示出有前途.
- 有效的CAR-T疗法依赖于识别特定的癌症细胞表面点.
- 大脑转移带来了独特的治疗挑战.
研究的目的:
- 开发一种用于大脑转移的新型CAR-T细胞疗法.
- 为了利用癌症干细胞表面抗原CD133作为治疗点.
主要方法:
- 利用CD133抗原为CAR-T细胞治疗的发展.
- 在大脑转移的背景下,CAR-T细胞免疫疗法的应用.
主要成果:
- 成功开发了一种针对CD133.3的CAR-T疗法.
- 在治疗大脑转移中提高疗效的潜力.
结论:
- 用CAR-T细胞向CD133是一个可行的策略,用于大脑转移.
- 这种方法为晚期癌症治疗提供了新的途径.
相关概念视频
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


